Financial Snapshot

Revenue
$26.61K
TTM
Gross Margin
61.68%
TTM
Net Earnings
-$4.953M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
4.29%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$12.00M
Q3 2024
Cash
Q3 2024
P/E
-0.7979
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue $89.16K $213.8K $48.27K $122.6K $240.3K $376.7K $657.3K $701.8K $924.7K $1.171M $710.0K $870.0K $770.0K $0.00 $0.00 $0.00
YoY Change -58.31% 342.99% -60.63% -48.96% -36.21% -42.69% -6.34% -24.11% -21.03% 64.92% -18.39% 12.99%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue $89.16K $213.8K $48.27K $122.6K $240.3K $376.7K $657.3K $701.8K $924.7K $1.171M $710.0K $870.0K $770.0K $0.00 $0.00 $0.00
Cost Of Revenue $35.99K $18.95K $5.881K $95.95K $81.67K $171.0K $323.6K $175.4K $152.0K $221.0K $160.0K $400.0K $400.0K $160.0K
Gross Profit $53.17K $194.9K $42.39K $26.67K $158.6K $205.7K $333.7K $526.3K $772.8K $950.0K $550.0K $470.0K $370.0K -$10.00K
Gross Profit Margin 59.64% 91.14% 87.82% 21.75% 66.01% 54.61% 50.76% 75.0% 83.57% 81.13% 77.46% 54.02% 48.05%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Selling, General & Admin $2.875M $3.410M $3.741M $3.168M $4.565M $4.423M $2.740M $2.545M $2.126M $3.867M $2.920M $1.090M $710.0K $20.00K $10.00K $10.00K
YoY Change -15.68% -8.85% 18.1% -30.62% 3.23% 61.41% 7.65% 19.73% -45.03% 32.43% 167.89% 53.52% 3450.0% 100.0% 0.0%
% of Gross Profit 5407.0% 1749.48% 8824.47% 11875.6% 2878.71% 2149.92% 821.19% 483.59% 275.1% 407.08% 530.91% 231.91% 191.89%
Research & Development $891.1K $1.459M $1.606M $4.274M $1.125M $151.8K $450.7K $0.00
YoY Change -38.95% -9.12% -62.42% 279.86% 641.32% -66.33%
% of Gross Profit 1675.75% 748.84% 3788.32% 16023.0% 709.44% 73.78% 135.08% 0.0%
Depreciation & Amortization $25.63K $27.45K $27.78K $28.92K $29.41K $7.350K $33.89K $30.25K $125.1K $135.5K $140.0K $0.00 $0.00 $20.00K
YoY Change -6.63% -1.18% -3.96% -1.66% 300.14% -78.31% 12.03% -75.81% -7.69% -3.22% -100.0%
% of Gross Profit 48.2% 14.08% 65.53% 108.43% 18.54% 3.57% 10.16% 5.75% 16.18% 14.26% 25.45% 0.0% 0.0%
Operating Expenses $3.877M $4.912M $5.558M $7.615M $5.720M $4.582M $3.225M $2.708M $5.891M $4.003M $3.060M $1.090M $720.0K $20.00K $10.00K $10.00K
YoY Change -21.07% -11.63% -27.0% 33.13% 24.84% 42.09% 19.06% -54.02% 47.17% 30.8% 180.73% 51.39% 3500.0% 100.0% 0.0%
Operating Profit -$3.788M -$4.698M -$5.510M -$7.492M -$5.561M -$4.376M -$2.891M -$2.182M -$5.118M -$3.053M -$2.510M -$620.0K -$350.0K -$30.00K
YoY Change -19.37% -14.74% -26.45% 34.72% 27.09% 51.37% 32.49% -57.36% 67.66% 21.62% 304.84% 77.14% 1066.67%

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Interest Expense $194.0K $151.0K -$565.7K -$511.0K -$1.622M -$1.959M -$27.11M -$3.722M -$280.1K -$75.21K -$1.360M -$260.0K -$70.00K $0.00 $0.00
YoY Change 28.53% -126.69% 10.71% -68.51% -17.19% -92.77% 628.42% 1228.89% 272.4% -94.47% 423.08% 271.43%
% of Operating Profit
Other Income/Expense, Net $17.31K $321.2K $299.5K $3.985M $1.137M
YoY Change -94.61% 7.24% -92.49% 250.44%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

No data

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Pretax Income -$3.770M -$4.377M -$5.211M -$3.507M -$6.048M -$6.584M -$29.71M -$5.904M -$4.666M -$3.128M -$3.840M -$880.0K -$410.0K -$20.00K -$10.00K -$10.00K
YoY Change -13.85% -16.0% 48.6% -42.03% -8.14% -77.83% 403.15% 26.53% 49.18% -18.55% 336.36% 114.63% 1950.0% 100.0% 0.0%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.770M -$4.377M -$5.211M -$3.507M -$6.040M -$6.512M -$29.71M -$5.904M -$4.666M -$3.128M -$3.840M -$890.0K -$410.0K -$20.00K -$10.00K -$10.00K
YoY Change -13.85% -16.0% 48.6% -41.94% -7.25% -78.08% 403.15% 26.53% 49.18% -18.55% 331.46% 117.07% 1950.0% 100.0% 0.0%
Net Earnings / Revenue -4228.9% -2046.77% -10794.33% -2859.63% -2513.79% -1728.85% -4519.55% -841.3% -504.58% -267.12% -540.85% -102.3% -53.25%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.45 -$0.61 -$802.4K -$645.7K -$1.714M -$2.598M -$12.77M -$3.468M -$3.001M -$2.252M -$3.282M -$839.6K -$803.9K -$11.30K -$2.331K -$500.0K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

No data

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Cash & Short-Term Investments $65.22K $68.62K $85.84K $592.1K $2.646M $279.8K $11.34K $92.46K $220.1K $53.12K $130.0K $10.00K $0.00 $0.00 $10.00K $0.00
YoY Change -4.95% -20.06% -85.5% -77.62% 845.72% 2367.11% -87.74% -57.98% 314.27% -59.14% 1200.0% -100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $44.89K $82.77K $84.63K $157.5K $213.3K $31.46K $13.21K $8.400K $64.25K $81.75K $80.00K $20.00K $0.00 $0.00 $0.00 $0.00
YoY Change -45.77% -2.2% -46.26% -26.16% 577.94% 138.15% 57.26% -86.93% -21.41% 2.19% 300.0%
Inventory
Prepaid Expenses
Receivables $77.01K $165.5K $57.86K $225.4K $187.4K $8.000K $29.95K $0.00 $27.75K $78.50K $310.0K $1.070M $530.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $187.1K $316.9K $228.3K $974.9K $3.047M $319.2K $54.50K $100.9K $312.1K $213.4K $530.0K $1.100M $530.0K $90.00K $10.00K $0.00
YoY Change -40.95% 38.79% -76.58% -68.0% 854.34% 485.74% -45.96% -67.68% 46.25% -59.74% -51.82% 107.55% 488.89% 800.0%
Property, Plant & Equipment $148.2K $347.0K $487.8K $618.1K $607.0K $44.37K $19.01K $22.16K $3.900K $6.190K $10.00K $10.00K $10.00K $0.00
YoY Change -57.28% -28.86% -21.09% 1.83% 1268.06% 133.4% -14.21% 468.21% -37.0% -38.1% 0.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $44.52K $44.52K $44.52K $44.52K $41.94K $13.42K $13.42K $67.63K $13.91K $157.8K $10.00K $0.00 $0.00 $0.00
YoY Change 0.0% 0.0% 0.0% 6.15% 212.52% 0.0% -80.16% 386.2% -91.18% 1477.9%
Total Long-Term Assets $201.8K $449.7K $591.7K $852.1K $886.7K $309.0K $284.4K $369.5K $1.093M $3.870M $3.900M $3.980M $3.980M $3.970M $0.00 $0.00
YoY Change -55.13% -24.0% -30.56% -3.9% 186.96% 8.65% -23.04% -66.2% -71.75% -0.77% -2.01% 0.0% 0.25%
Total Assets $388.9K $766.6K $820.0K $1.827M $3.933M $628.2K $338.9K $470.4K $1.405M $4.083M $4.430M $5.080M $4.510M $4.060M $10.00K $0.00
YoY Change
Accounts Payable $2.473M $2.013M $1.777M $1.181M $709.4K $1.555M $15.00K $315.0K $0.00 $0.00 $960.0K $620.0K $630.0K $20.00K $10.00K $0.00
YoY Change 22.86% 13.3% 50.5% 66.45% -54.37% 10264.33% -95.24% -100.0% 54.84% -1.59% 3050.0% 100.0%
Accrued Expenses $2.298M $2.029M $1.531M $1.416M $1.395M
YoY Change 13.28% 32.5% 8.17% 1.49%
Deferred Revenue
YoY Change
Short-Term Debt $1.606M $1.288M $1.012M $311.6K $311.6K $4.363M $186.6K $470.5K $1.752M $211.9K $120.0K $250.0K $190.0K $0.00 $0.00 $0.00
YoY Change 24.65% 27.35% 224.65% 0.0% -92.86% 2238.25% -60.35% -73.14% 726.86% 76.58% -52.0% 31.58%
Long-Term Debt Due $0.00 $31.58K $15.45K
YoY Change -100.0% 104.4%
Total Short-Term Liabilities $6.431M $5.364M $4.386M $3.052M $2.551M $6.127M $1.638M $2.451M $3.755M $1.938M $1.360M $2.250M $1.020M $20.00K $10.00K $0.00
YoY Change 19.9% 22.28% 43.71% 19.66% -58.37% 273.95% -33.15% -34.73% 93.77% 42.5% -39.56% 120.59% 5000.0% 100.0%
Long-Term Debt $72.47K $73.85K $174.2K $86.86K $0.00 $0.00 $2.016M $688.8K $5.530K $449.3K $600.0K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -1.87% -57.6% 100.51% -100.0% 192.7% 12355.33% -98.77% -25.12%
Other Long-Term Liabilities $3.838M $3.531M $3.221M $2.898M $2.441M $207.5K $577.3K $5.461M $927.2K $1.390M $2.240M $260.0K
YoY Change 8.7% 9.62% 11.14% 18.71% 1076.4% -64.05% -89.43% 488.96% -33.28% -37.96% 761.54%
Total Long-Term Liabilities $3.910M $3.605M $3.395M $2.985M $2.441M $207.5K $2.593M $6.150M $932.7K $1.839M $2.840M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 8.48% 6.17% 13.74% 22.27% 1076.4% -92.0% -57.83% 559.31% -49.28% -35.25%
Total Liabilities $10.21M $8.843M $7.664M $5.922M $4.911M $6.262M $4.232M $8.601M $4.688M $3.777M $4.200M $2.250M $1.020M $20.00K $10.00K $0.00
YoY Change 15.49% 15.39% 29.41% 20.59% -21.58% 47.98% -50.8% 83.46% 24.12% -10.07% 86.67% 120.59% 5000.0% 100.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Basic Shares Outstanding
Diluted Shares Outstanding 2.697M shares 1.448M shares 1.055M shares 1.141M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $3.9522 Million

About BioCorRx Inc.

BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. The company is headquartered in Anaheim, California. The company went IPO on 2010-08-31. Its Beat Addiction Recovery is a substance use disorder recovery program that typically includes its Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx Weight Loss Program is also a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists, nutritionists, fitness experts, and personal support from behavioral experts. The Company, through its subsidiary, BioCorRx Pharmaceuticals Inc., is engaged in the development of BICX104, a subcutaneous implantable naltrexone pellet for the treatment of both opioid and alcohol use disorders. The company is also engaged in the establishment of alcoholism and opioid addiction rehabilitation and treatment centers.

Industry: Services-Specialty Outpatient Facilities, NEC Peers: REGIONAL HEALTH PROPERTIES, INC AlerisLife Inc. SONIDA SENIOR LIVING, INC. HCA Healthcare, Inc. HQDA ELDERLY LIFE NETWORK CORP. IMAC Holdings, Inc. JOINT Corp SUNLINK HEALTH SYSTEMS INC